Align Technology (ALGN) Competitors $142.88 -2.86 (-1.96%) Closing price 04:00 PM EasternExtended Trading$143.25 +0.37 (+0.26%) As of 06:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ALGN vs. DXCM, HQY, HSIC, MEDP, QTRX, CAH, HAE, MCK, RMD, and WSTShould you be buying Align Technology stock or one of its competitors? The main competitors of Align Technology include DexCom (DXCM), HealthEquity (HQY), Henry Schein (HSIC), Medpace (MEDP), Quanterix (QTRX), Cardinal Health (CAH), Haemonetics (HAE), McKesson (MCK), ResMed (RMD), and West Pharmaceutical Services (WST). These companies are all part of the "medical" sector. Align Technology vs. Its Competitors DexCom HealthEquity Henry Schein Medpace Quanterix Cardinal Health Haemonetics McKesson ResMed West Pharmaceutical Services Align Technology (NASDAQ:ALGN) and DexCom (NASDAQ:DXCM) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, analyst recommendations, valuation, profitability, dividends and risk. Do analysts rate ALGN or DXCM? Align Technology currently has a consensus target price of $215.00, indicating a potential upside of 50.48%. DexCom has a consensus target price of $99.89, indicating a potential upside of 24.93%. Given Align Technology's higher probable upside, research analysts plainly believe Align Technology is more favorable than DexCom.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Align Technology 1 Sell rating(s) 5 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.60DexCom 0 Sell rating(s) 4 Hold rating(s) 15 Buy rating(s) 3 Strong Buy rating(s) 2.95 Do insiders and institutionals have more ownership in ALGN or DXCM? 88.4% of Align Technology shares are held by institutional investors. Comparatively, 97.8% of DexCom shares are held by institutional investors. 0.7% of Align Technology shares are held by company insiders. Comparatively, 0.3% of DexCom shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has more risk and volatility, ALGN or DXCM? Align Technology has a beta of 1.61, suggesting that its share price is 61% more volatile than the S&P 500. Comparatively, DexCom has a beta of 1.43, suggesting that its share price is 43% more volatile than the S&P 500. Which has higher valuation & earnings, ALGN or DXCM? DexCom has higher revenue and earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlign Technology$3.96B2.61$421.36M$5.9324.09DexCom$4.30B7.29$576.20M$1.4455.53 Is ALGN or DXCM more profitable? DexCom has a net margin of 13.29% compared to Align Technology's net margin of 11.04%. DexCom's return on equity of 30.41% beat Align Technology's return on equity.Company Net Margins Return on Equity Return on Assets Align Technology11.04% 13.36% 8.32% DexCom 13.29%30.41%10.08% Does the media favor ALGN or DXCM? In the previous week, DexCom had 10 more articles in the media than Align Technology. MarketBeat recorded 31 mentions for DexCom and 21 mentions for Align Technology. DexCom's average media sentiment score of 1.38 beat Align Technology's score of 1.10 indicating that DexCom is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Align Technology 12 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DexCom 24 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive SummaryDexCom beats Align Technology on 13 of the 17 factors compared between the two stocks. Get Align Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for ALGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ALGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALGN vs. The Competition Export to ExcelMetricAlign TechnologyMED/DENTAL IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.36B$15.07B$5.60B$9.82BDividend YieldN/A1.53%4.60%4.11%P/E Ratio24.0917.8930.2825.72Price / Sales2.612.54426.2096.43Price / Cash15.6316.0037.7558.93Price / Book2.653.708.456.01Net Income$421.36M$430.42M$3.25B$265.06M7 Day Performance2.96%3.67%4.05%2.80%1 Month Performance-28.31%3.03%4.27%1.65%1 Year Performance-35.06%15.02%36.25%29.33% Align Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALGNAlign Technology4.9529 of 5 stars$142.88-2.0%$215.00+50.5%-33.7%$10.36B$3.96B24.0920,945Positive NewsBuyback AnnouncementDXCMDexCom4.8708 of 5 stars$76.25-3.8%$99.89+31.0%+12.6%$29.90B$4.03B52.9510,300Positive NewsHQYHealthEquity4.245 of 5 stars$91.15+0.1%$118.55+30.1%+25.6%$7.88B$1.24B66.533,120News CoveragePositive NewsHSICHenry Schein4.1515 of 5 stars$70.02+3.0%$78.08+11.5%-0.6%$8.52B$12.67B21.8825,000News CoverageAnalyst RevisionMEDPMedpace4.3312 of 5 stars$432.43+2.2%$406.60-6.0%+21.8%$12.15B$2.11B32.155,900Positive NewsQTRXQuanterix2.102 of 5 stars$6.04+3.1%$13.50+123.5%-57.0%$301.70M$137.42M-4.65460Earnings ReportAnalyst ForecastCAHCardinal Health4.7354 of 5 stars$158.64+1.7%$158.07-0.4%+44.4%$37.86B$226.83B24.7548,900Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionHAEHaemonetics4.923 of 5 stars$76.26+2.0%$97.30+27.6%-27.4%$3.66B$1.36B23.043,023Earnings ReportAnalyst DowngradeMCKMcKesson4.496 of 5 stars$710.63+1.7%$710.17-0.1%+20.1%$88.91B$359.05B27.5145,000Positive NewsAnalyst ForecastInsider TradeAnalyst RevisionRMDResMed4.64 of 5 stars$291.30+4.3%$274.83-5.7%+30.8%$42.71B$5.15B30.639,980Positive NewsInsider TradeWSTWest Pharmaceutical Services4.649 of 5 stars$238.34-0.4%$320.71+34.6%-16.6%$17.14B$2.96B35.6810,600Positive News Related Companies and Tools Related Companies DXCM Alternatives HQY Alternatives HSIC Alternatives MEDP Alternatives QTRX Alternatives CAH Alternatives HAE Alternatives MCK Alternatives RMD Alternatives WST Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALGN) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Align Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Align Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access